Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOte Ads Regulatory News (OTES)

Share Price Information for Ote Ads (OTES)

Share Price is delayed by 15 minutes
Get Live Data
10.43    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $8.67b
OTES Live PriceLast checked at - London Stock Exchange

Intraday Ote Ads Share Chart

  • This share is an international stock.

EGM VOTING RESULTS

23 Dec 2016 11:21

RNS Number : 7481S
Hellenic Telecomms Organization S A
23 December 2016
 

Voting Results of the Extraordinary General Meeting of Shareholders of OTE S.A. of 22/12/2016

 

Athens, Greece - December 23, 2016 - Hellenic Telecommunications Organization SA (OTE SA), in accordance with the provisions of article 32, par. 1 of C.L 2190/20 and article 4.1.3.3 of the Athens Exchange Regulation, as in force, hereby releases the voting results of the Extraordinary General Meeting of Shareholders of December 22, 2016.

 

ISSUES

ITEM No 1:

Granting by the General Shareholders' Meeting of a special permission, pursuant to article 23a of C.L.2190/1920, for entering into the separate agreements ("Service Arrangements") between OTE S.A. and OTE Group companies on the one hand and Deutsche Telecom AG (DTAG) and Telekom Deutschland GmbH (TD GmbH) on the other hand for the provision by the latter of specific services for year 2017 under the approved "Framework Cooperation and Service Agreement".

ITEM No 2:

Granting by the General Shareholders' Meeting of a special permission pursuant to article 23a of C.L.2190/1920, for entering into: a) Framework Cooperation and Service Agreements and the relevant Service Arrangements between OTE S.A. and OTE Group companies on the one hand and Deutsche Telekom AG (DTAG) on the other hand for the provision for year 2017 by DTAG of Services related to Human Resources development and b) Service Agreements between OTE S.A and OTE Group companies on the one hand and DTAG on the other hand for the provision for year 2017 to DTAG of related advisory and support Services.

ITEM No 3:

Miscellaneous announcements.

 

 

REPRESENTED SHAREHOLDERS

TOTAL NUMBER OF SHARES

OWN SHARES

TOTAL NUMBER OF VOTING RIGHTS (ACCORDING TO THE LAW, THE OWN SHARES HAVE NOT VOTING RIGHTS)

TOTAL NUMBER OF REPRESENTED SHAREHOLDERS

TOTAL NUMBER OF VOTES OF REPRESENTED SHAREHOLDERS

TOTAL NUMBER OF VOTES OF REPRESENTED SHAREHOLDERS AS PERCENTAGE OF THE TOTAL NUMBER OF SHARES (AS PERCENTAGE OF THE TOTAL OF SHARE CAPITAL)

490.150.389

1.320.110

488.830.279

598

378.800.604

77,28%

 

 

VOTING RESULTS

AGENDA ITEM (SUBJECT NUMBER)

NUMBER OF VALID VOTES OF REPRESENTED SHAREHOLDERS

VALID VOTES OF REPRESENTED SHAREHOLDERS AS PERCENTAGE OF TOTAL REPRESENTED VOTES

VALID VOTES OF REPRESENTED SHAREHOLDERS AS PERCENTAGE OF THE TOTAL NUMBER OF SHARES (AS PERCENTAGE OF THE TOTAL OF SHARE CAPITAL)

IN FAVOUR

AGAINST

ABSTAIN

IN FAVOUR

AGAINST

ABSTAIN

IN FAVOUR

AGAINST

ABSTAIN

1

378.789.907

4.437

6.260

99,9972%

0,0012%

0,0017%

77,28%

0,001%

0,0013%

2

378.238.446

4.437

557.721

99,8516%

0,0012%

0,1472%

77,17%

0,001%

0,1138%

3

MISCELLANEOUS ANNOUNCEMENTS, NON VOTABLE ITEM

 

  

 

FOR FURTHER INFORMATION:

OTE GROUP INVESTOR RELATIONS

Τel. +30 210-6111574

Fax: +30 210-6111030

E-mail: iroffice@ote.gr

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBBBDDLBDBGLX
Date   Source Headline
2nd Jun 20268:11 amRNSPurchase of own shares
26th May 20267:00 amRNSPurchase of own shares
19th May 20261:00 pmRNSInvitation of Ordinary General Meeting 2026
18th May 20267:59 amRNSPurchase of own shares
11th May 20268:10 amRNSPurchase of own shares
8th May 20268:02 amRNS1st Quarter Results
5th May 20267:00 amRNSPurchase of own shares
27th Apr 20267:34 amRNSPurchase of own shares
20th Apr 20267:57 amRNSPurchase of own shares
7th Apr 20267:00 amRNSRelease date of Q1 2026 Financial Results
7th Apr 20267:00 amRNSPurchase of own shares
30th Mar 20267:54 amRNSPurchase of own shares
23rd Mar 20267:28 amRNSPurchase of own shares
16th Mar 20267:32 amRNSPurchase of Own Shares
16th Mar 20267:32 amRNSPurchase of Own Shares
9th Mar 20267:28 amRNSPurchase of own shares
27th Feb 20269:47 amRNSCommencement of 2026 Share Buyback Programme
26th Feb 20268:26 amRNSQ4 2025-FY 2025 Financial Results
29th Jan 20263:49 pmRNSAnnouncement-Completion of UFBB
26th Jan 202612:58 pmRNSFinancial Calendar 2026
23rd Jan 20262:38 pmRNSOwn shares purchase – OTE Shares Award Plan
22nd Jan 20268:14 amRNSRelease date of Q4 2025 Financial Results
12th Jan 20267:33 amRNSPurchase of own shares
5th Jan 20268:03 amRNSPurchase of own shares
29th Dec 20259:59 amRNSPurchase of own shares
29th Dec 20259:59 amRNSPurchase of own shares
19th Dec 20258:09 amRNSPurchase of own shares
19th Dec 20258:09 amRNSPurchase of own shares
18th Dec 20254:34 pmRNSAnnouncement-extraordinary dividend distribution
18th Dec 20254:34 pmRNSAnnouncement-extraordinary dividend distribution
15th Dec 20258:59 amRNSPurchase of own shares
8th Dec 20257:27 amRNSPurchase of Own Shares
4th Dec 20253:12 pmRNSAnnouncement of regulated information
2nd Dec 20252:17 pmRNSAnnouncement of regulated information
1st Dec 20258:17 amRNSPurchase of own shares
26th Nov 20251:25 pmRNSAnnouncement of regulated information
25th Nov 20252:10 pmRNSAnnouncement of regulated information
24th Nov 202512:33 pmRNSAnnouncement of regulated information
24th Nov 20257:50 amRNSPurchase of Own Shares
20th Nov 202511:35 amRNSAnnouncement of regulated information
20th Nov 202510:10 amRNSAnnouncement of regulated information
19th Nov 202510:13 amRNSAnnouncement of regulated information
19th Nov 20259:05 amRNSAnnouncement of regulated information
18th Nov 20252:47 pmRNSAnnouncement of regulated information
18th Nov 20251:52 pmRNSAnnouncement of regulated information
18th Nov 202512:44 pmRNSAnnouncement of regulated information
17th Nov 20257:59 amRNSPurchase of Own Shares
13th Nov 202510:35 amRNSUPDATE OF FINANCIAL CALENDAR 2025
13th Nov 20257:49 amRNS3rd Quarter Results
10th Nov 20258:36 amRNSPurchase of own shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.